Filing Details
- Accession Number:
- 0000950170-24-091964
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-06 17:00:03
- Reporting Period:
- 2024-08-02
- Accepted Time:
- 2024-08-06 17:00:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1463361 | Unity Biotechnology Inc. | UBX | Pharmaceutical Preparations (2834) | 264726035 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727640 | Marie Lynne Sullivan | 285 East Grand Ave South San Francisco CA 94080 | Cfo & Head Of Corp. Dev. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Disposition | 2024-08-02 | 139 | $1.53 | 56,061 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- Includes Restricted Stock Units which vest over time measured from the grant date.
- Represents adjusted total that includes an aggregate of 23,515 shares purchased under the Unity Biotechnology, Inc. 2018 Employee Stock Purchase Plan on May 15, 2023 and May 15, 2024 in transactions exempt from reporting pursuant to Rule 16b-3(c).
Billionaire Hedge Funds
